A team-based blood pressure intervention delivered through primary care reduced dementia risk by 15% over 7 years.
News|Slideshows|February 17, 2022
Hypertension Toolkit for Primary Care Practice: A Heart Month Checklist
Author(s)Grace Halsey
Recommendations on hypertension management from the US Surgeon General's office are summarized for at-a-glance American Heart Month reading.
Advertisement
The US Surgeon General's Call to Action to Control Hypertension is a comprehensive program of strategies developed to prevent or at least to slow the devastating effects of
In the spirit of American Heart Month 2022, we have summarized the
Advertisement
Related to this article
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.
The FDA approved an autoinjector device for lerodalcibep-liga and an updated indication reflecting cardiovascular risk reduction.
A Swedish observational study linked NOAC use to slower cognitive decline in individuals with atrial fibrillation and Alzheimer disease.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Advertisement
Advertisement
Trending on Patient Care Online
1
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
2
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
3
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
4
Clinical Inertia and Poor Measurement Technique Undermine BP Control
5